Avalo Therapeutics AVTX
NASDAQ AVTX
$15.66 +0.08 (+0.51%)
As of: Sep 30, 2026 · 11:49 AM EDT

Avalo Therapeutics (AVTX) Interest Coverage Ratio (2014 - 2015)

Updated

Avalo Therapeutics' (AVTX) Interest Coverage Ratio was -9.92 for Q3 2015, compared with -31.62 a year earlier.

Analysis

Avalo Therapeutics (AVTX) Interest Coverage Ratio (2014 - 2015) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 25.41
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 10.28
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 7.27
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 5.22
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -42.08
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Avalo Therapeutics 657.52 Mn 657.52 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2015 -9.92
Sep 30, 2014 -31.62
API Access

Avalo Therapeutics Interest Coverage Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-coverage-ratio&ticker=AVTX&period=max&api_key=YOUR_API_KEY